It has been known since the turn of the century that antigen-specific suppression of antibody production can be induced by the oral administration of antigen (1, 2). It was later shown that this mode of antigen administration also suppressed the ability of an animal to respond to the antigen with a delayed-type hypersensitivity response (3). Both of these phenomena have been repeatedly verified with modern techniques using protein (4-7) as well as cellular (8-10) antigens. It has further been shown that antigen-specific suppressor T cells (Ts) 1 are formed after the feeding of protein antigens (7, 11), contact sensitizing agents (6), and cellular antigens (9). Nonimmunoglobulin serum suppressor factors (10) and antigen-antibody complexes (8, 12) have also been reported to mediate unresponsiveness after antigen feeding. The present experiments demonstrate that antigen feeding leads to the production of at least two distinct, antigen-specific suppressor factors.
Materials and Methods
RBC. SRBC were obtained (Colorado Serum Co., Denver, Colo.) in sterile Alsever's solution. Before use, they were washed three times in cold RPMI-1640 (Microbiological Associates, Walkersville, Md.) and resuspended to the desired concentration. Horse RBC (HRBC) and burro RBC (BRBC) (Colorado Serum Co.) were similarly prepared.
Mice. C57BL/6, BALB/c, SJL/J, and DBA/2 mice were obtained from The Jackson Laboratory, Bar Harbor, Maine. C57BL/10, B 10.D2, and BALB.B were bred at Yale University (New Haven, Conn.), and were kindly donated by Dr. D. B. Murphy. C.AL20, BAB-14, and CB.20 were from our own colony at Yale University. All mice used were 6-10 wk old.
Feeding of SRBC. C57BL/6 mice were ether anesthetized and given 0.3 ml of a 50% SRBC suspension via stomach tube. The feedings were carried out daily for at least 5 d, and the mice were killed 18-24 h after the last feeding. In some experiments, BALB/c and B10.D2 were also treated in this manner.
Generation of Factors.
Spleen cells from the SRBC-fed mice (and unfed mice as controls) were washed three times in cold RPMI-1640 and were cultured in the same medium in a 5% CO2 atmosphere at a concentration of 2 × 107 cells/ml in 50-ml vessels (flask 3023; Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, Calif.). In every 50 ml of culture, 0.1 ml of 10% SRBC was added. After 48 h, the suspension was centrifuged at 5,000 g for 20 min, and the supernate was concentrated 10-20 times with an Amicon diafihration unit (Amicon Corp., Scientific Sys. Div., Lexington, Mass.) using a PM-10 filter. 5 ml of this concentrate was placed on a 2.5 X 100-cm Sephadex G-100,column (Pharmacia Fine Chemicals, Div. of Pharmaeia, Inc., Piseataway, N. J.), which was flowing at a constant rate of 0.2 ml/min with phosphatebuffered saline, pH 7.2, as the column buffer. The void volume that contained the immunoglobulins was discarded, and two distinct peaks were eluted from the column. One peak had a 60-75 × 10 a mol wt (fraction I [FrI]), and the other peak had a 30-40 × l0 s mol wt (fraction II [FrII] ). Each fraction was concentrated to 2 ml, dialyzed against RPMI-1640 for 24 h at 5°C, and stored at -70°C in 0.2-ml aliquots after filtration with a 0.22-/~m Millipore filter (Millipore Corp., Bedford, Mass.). Molecular weights were estimated by using a series of molecular weight standards to calibrate the Sephadex G-100 column: aldolase (158,000 tool wt); bovine serum albumin (BSA) (68,000 mol wt); ovalbumin (45,000 mol wt); and chymotrypsinogen A (25,000 mol wt).
Absorption of Factors. 0.5 ml of packed SRBC or HRBC was incubated with 1 ml of FrI or FrII for 45 min in a 37°C water bath. The cells were removed by centrifugation, and the resultant supernates were then tested for activity along with a sample from the same batch that had undergone the same incubation treatment without the RBC.
Preparation of Anti-Factor Antisera. Samples of blood were collected from two sheep (2318 and 2537) in sterile bottles that contained citrate at the Yale animal facilities. 2 ml of packed freshly drawn cells from sheep 2318 were incubated with 2 ml of FrI at 37°C for 45 min, and the same was done with the cells of sheep 2537 and FrII. After this adsorption step, the cells were washed once and brought up to 3 ml with phosphate-buffered saline and each was mixed with 3 ml of complete .Freund's adjuvant. The thick paste that resulted after vigorous mixing was then injected back into the sheep from which the SRBC were drawn. Intramuscular injections of 1.5 ml in each of four sites were given to each sheep. 1 mo later, the procedure was repeated with complete adjuvant. 4 wk after the second injection, the sheep were bled out, and the sera were tested against each of the factors by Ouchteriony gel diffusion and were then stored at -20°C.
Cell Separation. In some experiments, purified T and B cells were prepared according to the method of Wysocki and Sato (24) . Briefly, plastic Petri dishes (8-757-12, Fisher Scientific Co., Fair Lawn, N. J.) were precoated with goat anti-mouse immunoglobulin, and 3 ml (2 × 107 cells) of spleen cells was incubated on these plates for 70 min at 4°C. The nonadherent cells were removed and were used as a purified T cell population. After additional washes and a 45-min incubation at 37°C, the adherent cells were removed and used as a population of purified B cells. Staining with appropriate antisera showed only a slight (1-3%) cross-contamination.
In some eases, the purified T cells were further treated with anti-Lyt-2.2 serum (a gift of Dr. Fung-Win Shen, Memorial Sloan-Kettering Cancer Center, New York) plus complement. For this treatment, 2 × l0 T T cells were suspended in 2.5 ml of a 1:25 dilution of anti-Lyt-2.2 sera and incubated for 30 min at 37°C. After washing, the cells were resuspended in 2.5 ml of a 1: 10 dilution of rabbit complement for 30 min at 37°C. The cells were then washed three times, and staining revealed that ~30% of the treated cells were viable, with only 1-2% showing positive fluorescence with anti-Lyt-2.2 sera (25).
Cell Culture. 1 ml of a spleen cell suspension that contained 10 7 All cultures contained 0.025 ml of 1% SRBC, HRBC, or BRBC (~2 X l0 s RBC), and some also received 0.2 ml of a soluble factor preparation. Control cultures received either 0.2 ml of a control factor preparation, or were simply adjusted to volume with 0.2 ml RPMI-1640. These cultures were incubated for either 3 or 5 d at 37°C in a 5% CO2 atmosphere with 100% humidity. The use of this modified medium eliminated the need for daily culture nutritive additives.
Triplicate cultures were assayed for direct plaque-forming cells (PFC) (27) using the Cunningham and Szenberg modification (28) . Results are reported as mean PFC/culture + SEM.
Results

Generation of Specific, Nonimmunoglobulin Suppressor Factors. .The supernate from cul-
tures of spleen cells from SRBC-fed mice was always suppressive when assayed in an in vitro anti-SRBC Mishell-Dutton culture. Because antibody is known to be suppressive of this response, the supernate was fractionated on Sephadex G-100. The void volume was discarded; two peaks of approximate molecular weight 60,000-75,000 (Fr I) and 30,000-40,000 (FrII) were obtained. Table I demonstrates that each of these peaks contained active suppressive material, and that suppression was specific for SRBC, because the addition of the factor to in vitro cultures in which HRBC or BRBC were antigens did not suppress. Suppression titered out for both FrI and FrII at >1:10. All subsequent experiments use FrI and FrII at 1:6-1:10.
Both Factors Bind Specifically to the Antigen. Because of the specificity for SRBC of both of the factors, we next tested for binding of the factors to specific antigen. Both FrI and FrII bind to SRBC but do not bind to HRBC or BRBC (Table II) . Thus, antigen specificity of function reflects a specific antigen binding site on each factor.
Time-Course of Suppression.
We next examined the time-course of the effect of each factor during primary in vitro responses to SRBC (Table III) . Both factors suppress the response when PFC are measured at day 5 of culture. However, FrII added at the initiation of the culture led to marked increases in the number of SRBC PFC found on day 3 of culture, after which responses in the presence of FrII steadily declined to suppressed levels by day 5 of culture. FrI was suppressive at all times in all experiments.
Genetic Restrictions in the Effects of Suppressor Factors. Because interactions of T cells
or T cell-derived factors with other cells are frequently restricted by genetic differences at various loci, we next examined the ability of our suppressor factors to interact with spleen cells derived from various strains of mice. In particular, we determined the role of major histocompatibility complex (MHC) genes, immunoglobulin heavy-chain gene complex (Igh) genes, and genes in the B10 background on these factors.
As seen in Table IV , studies with three different sets of FrI derived from different strains of mice show no effect of MHC-or Igh-linked genes on the activity of this factor. However, FrI will not suppress responses in any strain with the B 10 background Percent suppression --(1 -response in presence of TsF/response in absence of TsF) X 100. Absence of suppression and matching disparities are boxed. (Table V) reveal a different pattern of restriction.
Here, MHC-linked genes and genes in the B10 background do not restrict the effect of FrII on the day 5 PFC response. However, in all cases in which the Igh genes of the responding cells differ from those of the FrII producer strain, no suppression is seen. Studies with allotype congenics such as the C.B20, which is a BALB/c mouse with Igh genes derived from C57BL, clearly map this restriction to the Igh-linked genes. Again, this finding negates trivial explanations of the activity of this factor. The finding of Igh-linked restriction in a factor that appears to induce a feedback-type of suppression is reminiscent of the recent finding of a similar restriction in feedback suppression by Eardley et al. (30) .
Analysis of the Mode of Action of Suppressor Factors.
At present, three facts point to T cells as the producers of these suppressor factors: antigen specificity, non-Ig nature, and the fact that spleen cells treated with anti-Thy-l.2 and complement do not produce suppressor factors (negative data not shown). However, the T cell nature of the producing cells has not been proven with purified T cells.
On the other hand, the cells activated by each suppressor factor have been partially characterized. First, the factors were added to cultures of B cells alone, or cultures of B cells plus Ly-1 T cells (or whole spleen). As seen in Table VI , neither factor affected (helped) either day-3 (not shown) or day-5 responses of B cells. When added to B cells plus Ly-1 T cells, Fr! did not suppress, but FrII led to increased responses on day 3 and day 5 of culture. Because both factors suppress the day-5 response of whole spleen, this suggested that FrI was a suppressor inducer factor similar to that described by Tada (31) , which required an Ly-2 + cell (Ly-123 or Ly-23) for its action, whereas FrII induced heightened activity in a cell set that had both helper and inducer of feedback suppression activities, similar to the Ly-1, Qa-1 + T cell set defined by the experiments of Cantor et al. (32) and McDougal et al. (33) .
To further explore this possibility, purified T cells or purified Ly-1 cells were euhured for 4 d with SRBC and either FrI or FrII. The cells were then recovered, thoroughly washed, and added to either B cells or B cells plus T cells from normal mice. The results are given in Table VII . FrI has no effect when precultured with anti-Ly-2-treated cells, whether these are added to B cells or B cells plus T cells. However, when it is cultured with unfractionated T cells, it induces potent suppression in these cells for both responses. In contrast, FrII has very pronounced effects on antiLy-2-treated cells. When Ly-1 cells precuhured with FrII and SRBC are added to B cells, a marked increase in helper activity at day 5 is seen. However, when these same cells are added to B plus T cell cultures, potent suppression is observed. Thus, FrII would appear to activate inducers of feedback suppression that are also Ly-1 helper T cells.
Discussion
These experiments demonstrate that the oral administration of antigen can induce, some days later, the production of at least two suppressive factors by spleen cells. These factors are both antigen specific and nonimmunoglobulin in nature, and their production is sensitive to anti-Thy-l.2 and complement. Thus, it is highly likely that they are produced by T cells. However, this needs to be confirmed ~ by positiveselection experiments now in progress.
It is our goal in these experiments to relate the activity of these factors to the known immunoregulatory circuits defined in several experimental systems. Thus, FrI most closely resembles the TsF ofTada et al. (1O, 20, 31 ), in that it will not work on strains with the B10 background, and does not affect Ly-1 helper cells directly. It rather serves to activate suppression from Ly-2 + T cells (Ly-123 or Ly-23 ~ells, or both). Preliminary data suggest that FrI is bound by anti-I-J antibody. However, it is not apparently MHC restricted in its activity. In this, it more closely resembles a series of TsF isolated by Benacerraf and his colleagues (14-lfi), which are antigen specific, I-J positive, and induce suppression in T cell populations that have not been further defined by anti-Ly fractionation. Perhaps these two sets of factors form different parts of the same suppressor-amplification loop, involving signals delivered by an Ly-23 cell to an Ly-123 cell, leading to increased Ly-23 suppressor activity.
FrII appears to be a novel suppressor factor. It apparently acts by inducing a subset of Ly-1 T cells that has both potent helper activity and the ability to induce feedback suppression. Thus, FrII would appear to activate the Ly-1, Qa-I + subset defined as containing both a helper T cell and the inducers of feedback suppression by Cantor et al. (32) . We believe both activities (help and induction of feedback suppression) derive from a single cell. This hypothesis is now being tested with these factors. The finding that the activity of FrII was restricted only by Igh-linked genes is also similar to the finding of such a restriction in the activity of the inducers of feedback suppression described by Eardley et al. (30) . Preliminary studies suggest FrII is I-A positive and I-J negative. Besides further studies aimed at defining the producing and accepting cells for these factors, their chemical nature is also being investigated. Thus far, we have su~zceeded in producing sheep anti-factor antisera, each of which will precipitate novel proteins from the surface of radio-iodinated mouse T cells (R. E. Cone, R. W. Rosenstein, and C. A. Janeway. Unpublished data.). Anti-FrI will also give a line in Ouchterlony diffusion with purified anti-trinitrophenyl TsF prepared by the method of Zembala and Asherson (23) . These antisera should allow the purification of these activities from a variety of different culture supernates. Finally, our studies will attempt to demonstrate that the incubation of these inducing TsF with their target populations gives rise to a set of effector TsF currently being analyzed by K. Yamauchi and R. K. Gershon (Manuscript in preparation.) at Yale University.
Summary
The feeding of sheep erythrocytes (SRBC) to mice leads to the production of two distinct T cell-derived suppressor factors by spleen cells. Each has been characterized for specificity, genetic restrictions, and cellular interactions.
Fraction I has a 60,000-75,000 mol wt, is specific for antigen, and is suppressive of primary in vitro anti-SRBC responses at all times. It is not restricted by major histocompatibility complex (MHC)-or Igh-linked genes, but it fails to suppress spleen cells derived from any strain of mouse with a B10 background. It acts on an Lyt-2 + T cell to increase suppressive activity. An antiserum has been prepared against this factor that reacts with other, unrelated T cell suppressor factors.
Fraction II has an ~30,000-40,000 mol wt, is specific for antigen, and has a dual effect on in vitro anti-SRBC responses. On day 3 of culture, it leads to augmentation of the response, whereas at day 5 it suppresses the response. It is not restricted by MHC genes, but it is restricted by Igh-linked genes. It acts by activating an Ly-1 T cell to both help and induce feedback suppression.
These factors, and the antisera prepared against them, should allow more precise dissection of the molecular pathways by which immunoregulatory cells communicate with one another.
